Showing 4871-4880 of 21485 results for "".
- Asthma Patients Favor SABA pMDIs Despite Sustainability Concernshttps://reachmd.com/news/asthma-patients-favor-saba-pmdis-despite-sustainability-concerns/2488491/Key Takeaways Among Australian adults with asthma interviewed for this qualitative report, environmental sustainability mattered to many participants, yet access to fast-acting SABA pMDIs remained the priority because these inhalers were widely perceived as the most effective
- Breast Milk HMOs Shape the Weaning Gut Microbiomehttps://reachmd.com/news/breast-milk-hmos-shape-the-weaning-gut-microbiome/2488495/Key Takeaways Human milk oligosaccharides in breast milk were reported to influence which gut bacteria thrive during the transition to solid foods, with that microbiome effect described as persisting later in life. Bacteria able to metabolize both human milk oligosac
- Lower-Dose Dexamethasone May Prevent Paclitaxel HSRshttps://reachmd.com/news/lower-dose-dexamethasone-may-prevent-paclitaxel-hsrs/2488493/Key Takeaways Among patients receiving weekly paclitaxel, lower-dose dexamethasone was reported as non-inferior to conventional dosing for hypersensitivity reactions during the second infusion. The compared regimens were dexamethasone 10 mg at the first infusion foll
- CSU Linked to Modest Stress-Related Psychiatric Riskhttps://reachmd.com/news/csu-linked-to-modest-stress-related-psychiatric-risk/2488478/Key Takeaways Newly diagnosed chronic spontaneous urticaria was associated with a modest increase in reaction to severe stress and adjustment disorders, with a hazard ratio of 1.15 and a 95% confidence interval of 1.09-1.22. In the matched incident-risk analysis, no
- LEO Pharma Closes Dersimelagon Acquisition as FDA Accepts NDAhttps://reachmd.com/news/leo-pharma-closes-dersimelagon-acquisition-as-fda-accepts-nda/2488489/LEO Pharma announced that the US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for dersimelagon for filing and granted Priority Review for the investigational treatment of erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP). The FDA has se
- TROP2 Marks Aggressive Colorectal Cancer Cellshttps://reachmd.com/news/trop2-marks-aggressive-colorectal-cancer-cells/2488480/Key Takeaways In reported sequencing analyses and translational models, high TROP2 expression in colorectal cancer was associated with metastasis development, significantly increased recurrence risk, poor prognosis, and treatment resistance. TROP2-positive colorectal
- Analysis: Negative Pressure Wound Therapy Linked to Fewer Complications After Prepectoral Breast Reconstructionhttps://reachmd.com/news/analysis-negative-pressure-wound-therapy-linked-to-fewer-complications-after-prepectoral-breast-reconstruction/2488485/Closed incision negative pressure wound therapy (ciNPWT) was associated with fewer early postoperative complications following immediate prepectoral breast reconstruction with polyurethane-coated implants, according to a retrospective study published in
- Nicotine Gum Eases Withdrawal in Smokeless Tobacco Cessationhttps://reachmd.com/news/nicotine-gum-eases-withdrawal-in-smokeless-tobacco-cessation/2488470/Key Takeaways In adults using smokeless tobacco in an Indian dental-clinic randomized comparison, 2 mg nicotine gum did not show a significant abstinence advantage over BISCA behavioral counseling. Nicotine gum showed stronger craving control, with 90% of participant
- Energy-Based HA Filler Degradation Varies by Laser Wavelengthhttps://reachmd.com/news/energy-based-ha-filler-degradation-varies-by-laser-wavelength/2488483/Cross-linked hyaluronic acid (HA) exposed to long-pulsed 1064-nm Nd laser irradiation showed substantial degradation in an ex vivo model, whereas microfocused ultrasound and other tested laser wavelengths produced comparatively little soluble HA, according to a study published in Polymers
- Vitamin D and Allergy: Urticaria Shows Strongest Signalhttps://reachmd.com/news/vitamin-d-and-allergy-urticaria-shows-strongest-signal/2488466/Key Takeaways Across 14 eligible meta-analytic articles covering 16 associations and 66,387 participants, the only class II association was lower serum 25(OH)D in urticaria (MD −9.35, 95% CI −12.27 to −6.44); serum 25(OH)D in allergic rhinitis was graded class III, SMD −1.29